In vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs

The potency of antimalarial dihydrofolate reductase inhibitors, alone and in synergistic combination with dihydropteroate synthetase inhibitors, against the Kenyan K39 strain of Plasmodium falciparum (pyrimethamine resistant) and against normal replicating human bone marrow cells in in vitro culture...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrobial agents and chemotherapy Vol. 39; no. 4; p. 948
Main Authors: Winstanley, P A, Mberu, E K, Szwandt, I S, Breckenridge, A M, Watkins, W M
Format: Journal Article
Language:English
Published: United States 01.04.1995
Subjects:
ISSN:0066-4804
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first